Nacl + Glucose Baxter (Sodium Chloride, Glucose)

Sodium chloride increases plasma sodium and chloride, expanding the extracellular fluid volume and improving osmotic balance. Glucose delivers immediate metabolic energy and stimulates cellular uptake of sodium, helping to shift fluid into the intravascular space. Together they address both volume depletion and energy needs during intravenous therapy.

The dose of NaCl + Glucose Baxter is determined by the prescribing clinician based on the patient’s weight, clinical condition, and laboratory values. Healthcare professionals calculate the required volume and infusion rate to achieve the desired fluid and electrolyte goals.

There is limited specific data on the use of this intravenous solution in pregnancy or lactation. Because it contains common electrolytes and glucose, it may be used when clinically indicated, but the prescriber should weigh potential benefits against any theoretical risks and monitor the mother and fetus closely.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and any required import documentation.

Compared with plain saline, NaCl + Glucose Baxter adds a carbohydrate source, which can help maintain blood glucose levels and provide energy during prolonged infusions. Unlike dextrose‑only solutions, it also corrects sodium and chloride deficits, making it suitable for patients needing both volume resuscitation and metabolic support.

Store the solution below 25 °C in its original packaging, protecting it from direct sunlight, moisture, and extreme temperature fluctuations. Do not freeze the product. Inspect the container for any signs of leakage or particulate matter before use.

The solution is administered intravenously, typically via a peripheral or central line. The infusion rate is set according to the patient’s clinical needs and monitored continuously for signs of fluid overload, electrolyte shifts, or changes in blood glucose.

Serious risks include severe electrolyte imbalance (especially hypernatremia), allergic reactions such as anaphylaxis, and fluid overload that can lead to pulmonary edema. Prompt recognition and monitoring are essential to mitigate these complications.

Patients with known hypersensitivity to sodium chloride, glucose, or any excipients in the formulation should avoid this product. It is also contraindicated in individuals with uncontrolled hypernatremia, severe fluid overload, or conditions where rapid glucose administration is unsafe without close monitoring.